Ultra-Efficient Pharmacokinetic Measurements in an Automated, Microscale Format
Pharmacokinetic and pharmacodynamic studies profile therapeutic agents and their effects across multiple timepoints, but PK/PD protein measurements are often limited by plate or bead-based methods with narrow dynamic range, large volume requirements and long assay times.
Correlia offers an automated platform that enables highly efficient protein measurements from as little as 2 µL of diluted biosample. This webinar focuses on case studies in therapeutic antibody development, with both IgG-generic and ligand-specific measurements of monoclonal antibodies.
Speaker
Dr. Samuel Tia
Co-founder and CSO | Correlia Biosystems
Samuel Tia works with Correlia’s scientific teams to expand its immunoassay test menus and deliver solutions for customer proteomic applications. He received a Ph.D. in Bioengineering from UC Berkeley, where his work in the Herr Lab led to a licensed patent, and a BS in Mechanical Engineering from the University of Florida, with industry experience in drug delivery and medical-grade manufacturing.
Key Learning Objectives
- Protein concentrations measured in a fraction of the time and sample volume of conventional immunoassays
- A “sample-in, answer-out” workflow with minimal user intervention
- Extended dynamic range when validated against competing immunoassays
Watch Now: Ultra-Efficient Pharmacokinetic Measurements in an Automated, Microscale Format
This webinar is available on demand. Fill in the form to watch the full recording — we'll email you the link too.
- January 26, 2022
- Dr. Samuel Tia, Correlia Biosystems
- kbiinfo@krishgen.com
- +91 22 49198700
Your details
Request the recording
Fill in your details and we'll email you the recording.
More Webinars
Shortcuts to Discovery and Characterization of Monoclonal Antibodies
Monoclonal antibody (mAb) discovery and characterization often face significant delays due to iterative screening cycles, late-stage functional failures, and downstream analytical bottlenecks. This webinar details five practical shortcuts that accelerate timelines from target validation to preclinical characterization.
View Webinar June 12, 2026Viral Vectors & CRISPR for Building Disease Models
Gene editing and viral vector technologies are transforming the development of advanced disease models for translational research.
View Webinar April 17, 2026Advanced Immunocompetent Primary Human Airway Models for Respiratory Disease Modeling
Advancements in human-relevant in vitro models are transforming how respiratory diseases are studied and how drug safety and efficacy are evaluated.
View Webinar